A Multicenter, Open Label, Uncontrolled, Phase Ii Trial Evaluating Safety and Efficacy of Venetoclax, Atezolizumab Andobinutuzumab in Richter Transformation From CLL
Hematological Oncology - United Kingdom
doi 10.1002/hon.4_2632
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley